openPR Logo
Press release

Infectious Disease IVD Market – Forecast to 2026

Infectious Disease IVD Market

Infectious Disease IVD Market

The findings reviewed by GME stated that the Global Infectious Disease In-Vitro Diagnostics Market would grow at a CAGR value of 4.6 percent from 2021 to 2026. The increasing geriatric population is the primary driving factor for the infectious disease in-vitro diagnostics market. Besides, the increasing number of infectious diseases, launch of advanced testing kits and beneficial features attributed by IVDs are propelling growth in the market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on " Infectious Disease In-Vitro Diagnostics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-infectious-disease-in-vitro-diagnostics-market-3241

By Product (Instruments [MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others], Reagents [MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others], Services [MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others]), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others), By End-use (Point of care, Central Laboratories, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA).
Key Market Insights
• As of 2021, the reagents segment is analyzed to be the most dominant segment in terms of instruments outlook
• The immunoassay technology is studied to have the highest share in the global infectious disease in-vitro diagnostics market
• COVID-19 being one of the most deadliest and infectious viral disease has topped the application segment in the market.
• Central laboratories are the most prominent end-users of the infectious disease in-vitro diagnostics market, thus hold the largest share from 2021-2026.
• BD, Abbott, Siemens Healthineers, Danaher, bioMérieux SA, AG,OraSure Technologies, Inc., Quidel Corporation, Hologic, Inc. (Gen Probe), QIAGEN, F. Hoffmann-La Roche, Ltd., and Bio-Rad Laboratories, Inc., are some of the prominent competitors in the market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-infectious-disease-in-vitro-diagnostics-market-3241

Product Outlook (Revenue, USD Billion, 2021-2026)
• Instruments
• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• COVID-19
• Others
• Reagents
• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• COVID-19
• Others
• Services
• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• COVID-19
• Others

Technology Outlook (Revenue, USD Billion, 2021-2026)
• Immunoassay
• Molecular Diagnostics
• Microbiology
• Others

Application Outlook (Revenue, USD Billion, 2021-2026)
• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• COVID-19
• Others

End-use Outlook (Revenue, USD Billion, 2021-2026)
• Point of care
• Central Laboratories
• Others

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The US.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease IVD Market – Forecast to 2026 here

News-ID: 2300588 • Views: 379

More Releases from Global Market Estimates Research & Consultants

Flexible Epoxy Resin Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Flexible Epoxy Resin Market is expected to grow from USD 592.4 Million in 2023 to USD 879.6 Million by 2028 and is projected to grow at a CAGR of 6.8% from 2023 to 2028. Conren Limited, DIC Corporation, Dow, Easy Composites, EPOXONIC, Hexion, INTERTRONICS, KUKDO Chemical (Kunshan) Co., Ltd., LymTal International, Inc., Mereco Technologies, and Nan Ya
Global Advanced Chemicals Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Advanced Chemicals Market is projected to grow at a CAGR of 4.8% from 2023 to 2028. Arkema INC., Evonik Industries AG, BASF SE, Merck Group, Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Lanxess AG, Johnson Matthey, Nouryon, Stepan Company among others, are some of the key players in the global Advanced Chemicals market. Browse 153 Market Data Tables and
Global Thyroid Gland Disorder Treatment Market
According to a new market research report published by Global Market Estimates, the Global Thyroid Gland Disorder Treatment Market is projected to grow at a CAGR of 4.3% from 2023 to 2028. Abbott Laboratories, AbbVie Inc, Allergan Plc, GlaxoSmithKline plc, Lannett Company, Inc, Merck & Co. Inc, Mylan N.V, Novartis AG, Pfizer Inc, and RLC Labs, Inc.among others are some of the key players operating in the global thyroid gland disorder
Global Boron Nitride Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Boron Nitride Market is projected to grow at a CAGR of 7.5% from 2023 to 2028. 3M Company, Saint-Gobain, Ceradyne, Inc., Momentive, H.C.Starck, UK Abrasives, Denka, Henze, Showa Denko Group, Shin-Etsu Chemical, Xinfukang, Qingzhou Fangyuan, DCEI, and Zibo Jonye Ceramic Technologies among others in the global boron nitride market. Browse 153 Market Data Tables and 113 Figures

All 5 Releases


More Releases for Hepatitis

Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each